Evidence map›Paper›PMID 42262875›Full record

ArticleThe Journal of clinical investigation2026

Single-cell spatial transcriptomics of formalin-fixed, paraffin-embedded biopsies reveals colitis-associated cell networks.

Elvira Mennillo, Madison L Lotstein, Gyehyun Lee, Julian H Hou, Vrinda Johri, Donna E Leet, Christina A Ekstrand, Jessica Tsui, Jun Yan He, Uma Mahadevan and 7 more

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Spatial Transcriptomics RevealsbioRxiv : the preprint server for biology · 2025
    Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Elvira MennilloDivision of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Madison L LotsteinBiomedical Sciences Graduate Program.
Gyehyun LeeDivision of Gastroenterology, Department of Medicine.
Julian H HouDivision of Gastroenterology, Department of Medicine.
Vrinda JohriUCSF CoLabs Initiative.
Donna E LeetDivision of Gastroenterology, Department of Medicine.
Christina A EkstrandBiomedical Sciences Graduate Program.
Jessica TsuiUCSF CoLabs Initiative.
Jun Yan HeDivision of Hematology/Oncology.
Uma MahadevanDivision of Gastroenterology, Department of Medicine.
Walter EckalbarUCSF CoLabs Initiative.
Ryan M GillDepartment of Pathology, and.
Christopher J BowmanDepartment of Pathology, and.
David Y OhDivision of Hematology/Oncology.
Gabriela K FragiadakisBiomedical Sciences Graduate Program.
Michael G KattahDivision of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Alexis J CombesDivision of Gastroenterology, Department of Medicine.

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
The role of γδ T cells in fetal and infant immune defense against malariaR01AI093615 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FEENEY, MARGARET E · 2011 to 2025
$9.1M
RESOURCE-BASED CENTER FOR THE ADVANCEMENT OF PRECISION MEDICINE IN RHEUMATOLOGYP30AR070155 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Mary C Nakamura · 2016 to 2026
$8.2M
Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis BR01DK103735 · NIDDK · CALIFORNIA PACIFIC MED CTR RES INSTITUTE · PI BARON, JODY L, COOPER, STEWART · 2016 to 2025
$7.2M
Restorative practice in repairing harm and promoting safe and inclusive practices in the laboratory.T32GM136547 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Adrian Erlebacher · 2020 to 2026
$4.5M
Targeting HIV-specific T cell differentiation programs to enhance post-treatment control of HIVR01AI170239 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Rachel Lena Rutishauser · 2022 to 2026
$4.0M
Sjögren's International Collaborative Clinical Alliance Next Generation Studies (SICCA-NextGen)U01DE028891 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SHIBOSKI, CAROLINE HELENE · 2020 to 2024
$4.0M
T cell immunity to CMV in utero and in early childhoodU01AI168390 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARGARET E FEENEY · 2022 to 2026
$3.9M
Immune determinants of progression from Oral Epithelial Dysplasia to Oral Squamous Cell Carcinoma by precision multiplexed imagingR01DE032033 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Matthew Spitzer · 2022 to 2026
$3.8M
Genetic regulation of epithlial injury in ulcerative colitisR01DK141679 · NIDDK · MAYO CLINIC ROCHESTER · PI KATTAH, MICHAEL GEORGE · 2025 to 2025
$2.8M
Epigenomic mechanisms of cardiac fibrosis and heart failureR01HL175312 · NHLBI · J. DAVID GLADSTONE INSTITUTES · PI Michael Alexanian · 2025 to 2026
$1.6M
Chromatin Regulation of Immune Cells in Myocardial InflammationR01HL181372 · NHLBI · J. DAVID GLADSTONE INSTITUTES · PI Michael Alexanian · 2025 to 2026
$1.6M
NHLBI NIH HHS R01 HL175312NHLBI NIH HHS R01 HL181372NIAID NIH HHS P30 AI027763NIAID NIH HHS R01 AI093615NIAID NIH HHS R01 AI170239NIAID NIH HHS U01 AI168390NIAMS NIH HHS P30 AR070155NIDCR NIH HHS R01 DE032033NIDCR NIH HHS U01 DE028891NIDDK NIH HHS R01 DK103735NIDDK NIH HHS R01 DK141679NIGMS NIH HHS T32 GM136547
6 · The paper itself

Abstract

Imaging-based, single-cell, spatial transcriptomics (iSCST) of FFPE tissue enables comprehensive analysis of archived specimens while preserving spatial context, critical to an understanding of ulcerative colitis (UC) pathology. Here, we deployed a robust framework for applying iSCST to clinical FFPE mucosal biopsies from patients with UC or immune checkpoint inhibitor-induced colitis, as well as patients serving as healthy controls. iSCST using custom Xenium gene panels enabled precise detection of diverse cell subsets and disease-specific genes. We mapped transcriptionally distinct fibroblast subsets within mucosal niches, including inflammation-associated fibroblasts (IAFs), and identified colitis-specific neighborhoods formed by IAFs, monocytes, and neutrophils. Transcriptional signatures and spatial neighborhoods uncovered through iSCST were associated with vedolizumab (VDZ) response, with nonresponders exhibiting either an innate IAF-monocyte-neutrophil signature or adaptive gut-associated lymphoid tissue signature, while responders showed enrichment of an epithelial cellular neighborhood. These signatures were validated in an internal and an external dataset, supporting the existence of 2 distinct archetypes of treatment resistance to VDZ in UC. This iSCST framework provides a powerful approach for analyzing FFPE tissues, offering insights into colitis-associated cellular networks and identifying biomarkers to enhance patient risk stratification in routine clinical workflows.

Indexed as

Colitis, UlcerativeSingle-Cell AnalysisTranscriptomeAntibodies, Monoclonal, HumanizedBiopsyFemaleFibroblastsFormaldehydeHumansIntestinal MucosaMaleMonocytesNeutrophilsParaffin EmbeddingSingle-Cell Gene Expression AnalysisSpatial TranscriptomicsAntibodies, Monoclonal, HumanizedFormaldehydevedolizumabGastroenterologyInflammationInflammatory bowel diseaseTranscriptomics

Identifiers

PMID42262875
PMCPMC13367960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.